首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

2050567

白蛋白市場：依產品類型、應用、形態、最終用戶及地區分類

Albumin Market, By Product Type, By Application, By Form, By End User, By Geography

出版日期: 2026年03月17日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年白蛋白市場規模估計為78億美元，預計2033年將達到131.1億美元。預計2026年至2033年，其複合年成長率將達7.7%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	78億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.70%	2033年市場規模預測：	131.1億美元

全球白蛋白市場是生物製藥行業的重要組成部分，涵蓋了用於治療和診斷應用的人類血清白蛋白 (HSA) 和重組白蛋白產品。白蛋白是人類血漿中最豐富的蛋白質，約佔血漿總蛋白含量的 50% 至 60%，在維持膠體滲透壓、運輸包括激素、脂肪酸和藥物在內的各種物質以及作為評估營養狀況和肝功能的生物標記方面發揮著至關重要的作用。

該市場主要面向臨床應用，例如血液容量替代療法、低白蛋白血症治療、燒傷和創傷治療、肝病管理以及腎病綜合症治療。此外，白蛋白也廣泛用於細胞培養基、疫苗生產、藥物製劑以及各種研究應用。由於大多數白蛋白產品源自於血液，因此該市場具有嚴格的法規結構，這推動了血漿分餾技術和重組生產方法的持續創新。血漿供應、監管核准流程和醫療基礎設施的區域差異顯著影響著市場動態，而人們對白蛋白治療益處的認知不斷提高，以及其在再生醫學和藥物遞送系統等領域的應用不斷擴展，持續推動著全球已開發國家和新興市場的發展。

市場動態

全球白蛋白市場受多種關鍵因素驅動，包括慢性疾病（如肝硬化、腎病症候群和心血管疾病）患病率的上升（這些疾病需要白蛋白替代療法），以及需要輸液的外科手術和創傷病例數量的增加。全球老化人口的不斷成長，以及低白蛋白血症及其相關併發症的易感性，也顯著推動了市場需求。此外，白蛋白在生物製藥製造、疫苗生產和細胞培養基等領域的應用不斷擴展，也推動了市場成長；同時，血漿分餾和純化製程的技術進步正在提高產品品質和產量。

然而，市場也存在著許多限制因素。主要因素是作為原料的人血漿供應有限，導致供需失衡和價格波動。血液製品的嚴格監管要求（例如廣泛的安全檢測和品管措施）增加了生產成本和上市時間。儘管實施了嚴格的篩檢程序，病原體傳播的安全隱患仍是市場接受度面臨的挑戰。此外，血漿採集、處理和純化技術相關的高昂生產成本限制了市場進入，尤其是在價格敏感地區。儘管如此，重組白蛋白產品的開發帶來了巨大的機遇，它無需依賴人血漿，從而消除了相關的安全隱患，同時還能提供穩定的品質和無限的供應。生技產業的擴張，尤其是在新興市場，以及白蛋白在新型藥物遞送系統和再生醫學應用的日益普及，都帶來了可觀的成長機會。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球白蛋白市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球白蛋白市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球白蛋白市場時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

CSL Behring
Grifols, SA
Octapharma AG
Baxter International Inc.
Albumedix Ltd.
Biotest AG
HiMedia Laboratories Pvt. Ltd.
Medxbio Pte Ltd.
China Biologic Products, Inc.
Thermo Fisher Scientific
Ventria Bioscience Inc.
SeraCare Life Sciences
Merck KGaA
Takeda Pharmaceutical Company Limited
Kamada Ltd.

第10章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8587

Albumin Market is estimated to be valued at USD 7.80 Bn in 2026 and is expected to reach USD 13.11 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7.80 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.70%	2033 Value Projection:	USD 13.11 Bn

The global albumin market represents a critical segment within the biopharmaceutical industry, encompassing human serum albumin (HSA) and recombinant albumin products that serve essential therapeutic and diagnostic applications. Albumin, the most abundant protein in human plasma, constitutes approximately 50-60% of total plasma proteins and plays vital roles in maintaining oncotic pressure, transporting various substances including hormones, fatty acids, and drugs, and serving as a biomarker for nutritional and liver function assessment.

The market primarily caters to clinical applications including volume replacement therapy, treatment of hypoalbuminemia, burn and trauma care, liver disease management, and nephrotic syndrome treatment. Additionally, albumin finds extensive use in cell culture media, vaccine production, drug formulation, and various research applications. The market is characterized by stringent regulatory frameworks due to the blood-derived nature of most albumin products, driving continuous innovation in plasma fractionation technologies and recombinant production methods. Geographic variations in plasma availability, regulatory approval processes, and healthcare infrastructure significantly influence market dynamics, while growing awareness of albumin's therapeutic benefits and expanding applications in regenerative medicine and drug delivery systems continue to shape market evolution across developed and emerging economies worldwide.

Market Dynamics

The global albumin market is propelled by several key drivers, including the rising prevalence of chronic diseases such as liver cirrhosis, nephrotic syndrome, and cardiovascular disorders that necessitate albumin replacement therapy, coupled with increasing surgical procedures and trauma cases requiring volume expansion solutions. The growing geriatric population worldwide, which is more susceptible to hypoalbuminemia and related complications, significantly contributes to market demand. Additionally, expanding applications in cell culture media for biopharmaceutical manufacturing, vaccine production, and research activities drive market growth, while technological advancements in plasma fractionation and purification processes enhance product quality and yield.

However, the market faces considerable restraints, primarily the limited availability of human plasma as a raw material, which creates supply-demand imbalances and price volatility. Stringent regulatory requirements for blood-derived products, including extensive safety testing and quality control measures, increase production costs and time-to-market. Safety concerns related to potential pathogen transmission, despite rigorous screening protocols, continue to pose challenges for market acceptance. Furthermore, high production costs associated with plasma collection, processing, and purification technologies limit market accessibility, particularly in price-sensitive regions. Nevertheless, significant opportunities emerge from the development of recombinant albumin products that eliminate dependency on human plasma and associated safety concerns, while offering consistent quality and unlimited supply potential. The expanding biotechnology sector, particularly in emerging markets, presents lucrative growth prospects, as does the increasing adoption of albumin in novel drug delivery systems and regenerative medicine applications.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global albumin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include leading plasma fractionation companies, biopharmaceutical manufacturers, and albumin product developers
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global albumin market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2021 - 2033)
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Application Insights (Revenue, USD Bn, 2021 - 2033)
Therapeutics
- Oncology
- Liver Diseases
- Hypovolemia and Shock
- Burn Treatment
- Others (Trauma and Surgery)
Excipient and Formulation
- Vaccine Manufacturing
- Drug Delivery
Diagnostics
- Blood Protein Analysis
- Serum Protein Electrophoresis
Research
- Cell Culture Media
- Protein Stability Studies
Form Insights (Revenue, USD Bn, 2021 - 2033)
Liquid Albumin
Lyophilized/Powdered Albumin
End User Insights (Revenue, USD Bn, 2021 - 2033)
Pharmaceutical and Biotechnology Industry
Hospitals and Clinics
Diagnostic Laboratories
Research Institutes
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
CSL Behring
Grifols, S.A.
Octapharma AG
Baxter International Inc.
Albumedix Ltd.
Biotest AG
HiMedia Laboratories Pvt. Ltd.
Medxbio Pte Ltd.
China Biologic Products, Inc.
Thermo Fisher Scientific
Ventria Bioscience Inc.
SeraCare Life Sciences
Merck KGaA
Takeda Pharmaceutical Company Limited
Kamada Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Albumin Market, By Product Type
- Global Albumin Market, By Application
- Global Albumin Market, By Form
- Global Albumin Market, By End User
- Global Albumin Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Albumin Market, By Product Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Human Serum Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Bovine Serum Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Recombinant Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Albumin Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Oncology
  - Liver Diseases
  - Hypovolemia and Shock
  - Burn Treatment
  - Others (Trauma and Surgery)
Excipient and Formulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Vaccine Manufacturing
  - Drug Delivery
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Blood Protein Analysis
  - Serum Protein Electrophoresis
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Cell Culture Media
  - Protein Stability Studies

6. Global Albumin Market, By Form, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Liquid Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Lyophilized/Powdered Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Albumin Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharmaceutical and Biotechnology Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Albumin Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Grifols, S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Octapharma AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Albumedix Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotest AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HiMedia Laboratories Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medxbio Pte Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
China Biologic Products, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ventria Bioscience Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SeraCare Life Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kamada Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies